310 related articles for article (PubMed ID: 17098546)
1. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
2. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
4. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor naked DNA gene transfer enhances thrombus recanalization and resolution.
Waltham M; Burnand K; Fenske C; Modarai B; Humphries J; Smith A
J Vasc Surg; 2005 Dec; 42(6):1183-9. PubMed ID: 16376212
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolution.
Modarai B; Humphries J; Burnand KG; Gossage JA; Waltham M; Wadoodi A; Kanaganayagam GS; Afuwape A; Paleolog E; Smith A
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1753-9. PubMed ID: 18669887
[TBL] [Abstract][Full Text] [Related]
7. Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice.
Bouzeghrane F; Zhang X; Gevry G; Raymond J
J Vasc Surg; 2008 Dec; 48(6):1575-84. PubMed ID: 18829216
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.
Nosaka M; Ishida Y; Kimura A; Kuninaka Y; Taruya A; Furuta M; Mukaida N; Kondo T
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2638-2650. PubMed ID: 30354252
[TBL] [Abstract][Full Text] [Related]
9. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
[TBL] [Abstract][Full Text] [Related]
10. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.
Singh I; Burnand KG; Collins M; Luttun A; Collen D; Boelhouwer B; Smith A
Circulation; 2003 Feb; 107(6):869-75. PubMed ID: 12591758
[TBL] [Abstract][Full Text] [Related]
11. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.
Henke PK; Varga A; De S; Deatrick CB; Eliason J; Arenberg DA; Sukheepod P; Thanaporn P; Kunkel SL; Upchurch GR; Wakefield TW
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1130-7. PubMed ID: 15105284
[TBL] [Abstract][Full Text] [Related]
12. Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
Sood V; Luke C; Miller E; Mitsuya M; Upchurch GR; Wakefield TW; Myers DD; Henke PK
Ann Vasc Surg; 2010 Feb; 24(2):233-41. PubMed ID: 20142002
[TBL] [Abstract][Full Text] [Related]
13. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.
Dewyer NA; Sood V; Lynch EM; Luke CE; Upchurch GR; Wakefield TW; Kunkel S; Henke PK
J Surg Res; 2007 Oct; 142(2):357-63. PubMed ID: 17574586
[TBL] [Abstract][Full Text] [Related]
14. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
[TBL] [Abstract][Full Text] [Related]
15. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW
Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610
[TBL] [Abstract][Full Text] [Related]
16. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and upregulation of hypoxia-inducible factor 1{alpha} stimulate venous thrombus recanalization.
Evans CE; Humphries J; Mattock K; Waltham M; Wadoodi A; Saha P; Modarai B; Maxwell PH; Smith A
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2443-51. PubMed ID: 20930171
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of labelled monocytes by experimental venous thrombi.
McGuinness CL; Humphries J; Waltham M; Burnand KG; Collins M; Smith A
Thromb Haemost; 2001 Jun; 85(6):1018-24. PubMed ID: 11434678
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats.
Meng QY; Li XQ; Yu XB; Lei FR; Jiang K; Li CY
Chin Med J (Engl); 2010 Feb; 123(4):471-7. PubMed ID: 20193489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
